These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 98196)
1. Token economy, pimozide and chronic schizophrenia. McCreadie RG; Main CJ; Dunlop RA Br J Psychiatry; 1978 Aug; 133():179-81. PubMed ID: 98196 [TBL] [Abstract][Full Text] [Related]
2. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy. Wilson LG; Roberts RW; Gerber CJ; Johnson MH J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441 [TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients. Kolivakis T; Azim H; Kingstone E Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674 [No Abstract] [Full Text] [Related]
4. Comparison of pimozide and chlorpromazine in acute schizophrenia. Pecknold JC; McClure DJ; Allan T; Wrzesinski L Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898 [TBL] [Abstract][Full Text] [Related]
8. Pimozide in the treatment of newly admitted schizophrenic patients. Chouinard G; Annable L Psychopharmacology (Berl); 1982; 76(1):13-9. PubMed ID: 6805002 [TBL] [Abstract][Full Text] [Related]
9. Symptom changes in chronic schizophrenic patients on a token economy: a controlled experiment. Baker R; Hall JN; Hutchinson K; Bridge G Br J Psychiatry; 1977 Oct; 131():381-93. PubMed ID: 922265 [TBL] [Abstract][Full Text] [Related]
10. The token economy in the National Health Service: possibilities and limitations. Presly AS; Black D; Gray A; Hartie A; Seymour E Acta Psychiatr Scand; 1976 Apr; 53(4):258-70. PubMed ID: 1274646 [TBL] [Abstract][Full Text] [Related]
11. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia. McCreadie R; Mackie M; Morrison D; Kidd J Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596 [TBL] [Abstract][Full Text] [Related]
12. Pimozide in the maintenance treatment of apathetic and emotionally withdrawn schizophrenics. Cheadle AJ; Freeman HL Curr Med Res Opin; 1979; 6(1):35-43. PubMed ID: 378556 [TBL] [Abstract][Full Text] [Related]
14. Activity in chronic schizophrenic patients: comparison of pimozide with fluphenazine in a double blind trial. Sims AC; Burnside IG Psychol Med; 1975 May; 5(2):161-4. PubMed ID: 1099598 [TBL] [Abstract][Full Text] [Related]
15. Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study. Haas S; Beckmann H Pharmacopsychiatria; 1982 Mar; 15(2):70-4. PubMed ID: 7043498 [TBL] [Abstract][Full Text] [Related]
16. Token economy in a hospital rehabilitation system. Baker R J Adv Nurs; 1988 Sep; 13(5):631-9. PubMed ID: 3225367 [TBL] [Abstract][Full Text] [Related]
17. High dosage haloperidol in chronic schizophrenia. McCreadie RG; MacDonald IM Br J Psychiatry; 1977 Sep; 131():310-6. PubMed ID: 334315 [TBL] [Abstract][Full Text] [Related]
18. A controlled evaluation of token economy procedures with chronic schizophrenic patients. Hall JN; Baker RD; Hutchinson K Behav Res Ther; 1977; 15(3):261-83. PubMed ID: 597094 [No Abstract] [Full Text] [Related]
19. Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent? van Kammen DP; Hommer DW; Malas KL Neuropsychobiology; 1987; 18(3):113-7. PubMed ID: 3453426 [TBL] [Abstract][Full Text] [Related]
20. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group. Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]